Relationships Between IL-13 and IL-4 Genotypes and Aeroallergens with Risk of Allergic Rhinitis in Iranian-Azeri
Pediatric Allergy, Immunology, and Pulmonology · 2020-03 · 33 (1) · 33-38
DOI: 10.1089/ped.2019.1099 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Pediatric Allergy, Immunology, and Pulmonology, online erschienen am 17.03.2020. Verfasst von Nazila Valatabar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Animal Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran. Hauptthemen laut MEDLINE: Genetic Predisposition to Disease. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Up to 40% of the world populations are affected by allergic rhinitis (AR). Interplay between genetics, epigenetics, and environmental factors leads to allergic disease.
Objective
In this study, we evaluated the accompaniment between polymorphic variants of IL-13 and IL-4 and aeroallergens among Iranian-Azeri children and adolescent in AR's risk.
Methods
Five-hundred AR patients and 300 healthy individuals were enrolled in this study after diagnosis via blood testing for IgE and skin prick test by subspecialty of Allergy and Immunology from Azerbaijan, northwest of Iran, from 2017 to 2019. Genomic DNA was prepared from all samples for genotyping of IL-4 and IL-13 .
Results
We identified genetic variation of IL-13 and IL-4 and important aeroallergens that could increase the AR risk during childhood and adolescent. The risk of AR increased in the subjects with +2044GA genotype of IL13 [adjusted odds ratio (OR), 1.80; 95% confidence interval (CI), 0.97–3.33] and −590CT genotype of IL4 (adjusted OR, 1.94; 95% CI, 1.00–3.87) in childhoods, compared with the control subjects. However, none of genotypes and allele frequencies of IL4 −590C/T and IL13 +2044G/A polymorphisms revealed significant variation between the AR patients and controls in adulthood. The frequency of sensitization to pollens was high in all genotypes of IL4 −590C/T and IL13 +2044G/A polymorphisms in both age groups of AR patients.
Conclusion
AR is considered to be the most common form of atopic disease. Susceptible individuals had family history of allergic disease and indicated sensitivity to various environmental factors. In this study, pollen and feather played an important role in occurrence of AR. Childhood with GA at IL13 +2044 and CT at IL4 −590 are at increased risk for AR. Moreover, further studies with more samples are required to confirm our findings and also to help us develop new procedure for genetically detecting more efficient proceedings of prevention and intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Animal Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran.
- Immunology Research Center of Tabriz, TB and Lung Research Center of Tabriz, Children Hospital, Tabriz University of Medical Sciences, Tabriz, Iran.
Zitieren
APA
Valatabar, N., Hosseinpourfeizi, M., Safaralizadeh, R., & Sadeghi-Shabestari, M. (2020). Relationships Between IL-13 and IL-4 Genotypes and Aeroallergens with Risk of Allergic Rhinitis in Iranian-Azeri. Pediatric Allergy, Immunology, and Pulmonology, 33(1), 33-38. https://doi.org/10.1089/ped.2019.1099
Vancouver
Valatabar N, Hosseinpourfeizi M, Safaralizadeh R, Sadeghi-Shabestari M. Relationships Between IL-13 and IL-4 Genotypes and Aeroallergens with Risk of Allergic Rhinitis in Iranian-Azeri. Pediatric Allergy, Immunology, and Pulmonology. 2020;33(1):33-38. doi:10.1089/ped.2019.1099
BibTeX
@article{Valatabar2020,
author = {Valatabar, Nazila and Hosseinpourfeizi, Mohammadali and Safaralizadeh, Reza and Sadeghi-Shabestari, Mahnaz},
title = {Relationships Between IL-13 and IL-4 Genotypes and Aeroallergens with Risk of Allergic Rhinitis in Iranian-Azeri},
journal = {Pediatric Allergy, Immunology, and Pulmonology},
year = {2020},
volume = {33},
number = {1},
pages = {33--38},
doi = {10.1089/ped.2019.1099}
}
EUVIMED